skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Join distinguished cancer and industry experts as they explore what a shift in cancer treatment – from late stage intervention to an early detection paradigm – would mean for patient outcomes, cancer costs, technology, development, regulatory affairs, and more.
Explore this new approach toward focusing on early stage cancer detection, including discussion of diagnostics in this area, such as biomarker identification, liquid biopsies, and monitoring technologies.

Topics covered include:

  • Cancer types relevant to early detection and how the patient journey could change
  • Barriers to the shift to an early detection paradigm
  • Shifts in patient guidelines
  • Government and regulatory roles in early detection tools and tech
  • Addressing end-of-life cancer care costs
  • The future of early detection



View the slides here